mouse monoclonal IgG2a; p53 Antibody (DO-1) is an IgG2a κ mouse monoclonal p53 antibody (also designated tumor suppressor protein p53 antibody or TP53 antibody) that detects the p53 protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM. p53 Antibody (DO-1) is available as both the non-conjugated anti-p53 antibody form, as well as multiple conjugated forms of anti-p53 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The 53 protein is a DNA-binding, oligomerization domain- and transcription activation domain-containing tumor suppressor. The p53 protein upregulates growth arrest and apoptosis-related genes in response to stress signals, thereby influencing programmed cell death, cell differentiation, and cell cycle control mechanisms. The p53 Antibody can stain both the nucleus and cytoplasm, as the p53 protein localizes to the nucleus, yet can be chaperoned to the cytoplasm by the negative regulator, MDM2. MDM2 is an E3 ubiquitin ligase that is upregulated in the presence of active p53, where it poly-ubiquitinates p53 for proteasome targeting. p53 fluctuates between latent and active DNA-binding conformations and is differentially activated through posttranslational modifications, including phosphorylation and acetylation. phospho-specific p53 Antibodies can differentiate between phosphorylated and non-phosphorylated p53. Mutations in the DNA-binding domain (DBD) of p53, amino acids 110-286, can compromise energetically-favorable association with cis elements and are implicated in several human cancers. p53 Antibody is therefore an important reagent for cancer research.